Status:
COMPLETED
Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell Carcinoma
Lead Sponsor:
Samsung Medical Center
Conditions:
Metastatic Esophageal Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Esophageal squamous cell carcinoma is considerably more prevalent in East Asia. Despite of relatively high prevalence of esophageal SCC, prognosis is very poor with limited options of effective chemot...
Eligibility Criteria
Inclusion
- recurrent, metastatic esophageal SCC
- received either FP or XP as first-line chemotherapy.
Exclusion
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT01472419
Start Date
March 1 2012
End Date
March 1 2013
Last Update
April 9 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.